A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

RECRUITING

Royal Prince Alfred Hospital, Camperdown

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

RECRUITING

The Alfred Hospital, Melbourne

RECRUITING

Austin Hospital, Heidelberg

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

SUSPENDED

Memorial Sloan Kettering Cancer Center, New York

RECRUITING

University of Pennsylvania, Philadelphia

SUSPENDED

Thomas Jefferson University, Philadelphia

RECRUITING

Norton Cancer Institute, Louisville

RECRUITING

Barbara Ann Karmanos Cancer Institute, Detroit

RECRUITING

University of Iowa Hospital and Clinics, Iowa City

SUSPENDED

Medical College Of Wisconsin, Milwaukee